Resistance to KRAS g12c inhibitors in non-small cell lung cancer

dc.contributorCardona, Andrés Felipe [https://orcid.org/0000-0003-3525-4126]
dc.contributorBlaquier, Juan Bautista [https://orcid.org/0000-0002-7197-5986]
dc.creatorRecondo, Gonzalo
dc.creatorCardona, Andrés Felipe
dc.creatorBlaquier, Juan Bautista
dc.date.accessioned2022-09-21T13:58:26Z
dc.date.accessioned2023-06-05T14:37:12Z
dc.date.available2022-09-21T13:58:26Z
dc.date.available2023-06-05T14:37:12Z
dc.date.created2022-09-21T13:58:26Z
dc.date.issued2021
dc.identifier2234-943X
dc.identifierhttp://hdl.handle.net/20.500.12495/9069
dc.identifierhttps://doi.org/10.3389/fonc.2021.787585
dc.identifierinstname:Universidad El Bosque
dc.identifierreponame:Repositorio Institucional Universidad El Bosque
dc.identifierrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/6639978
dc.languageeng
dc.publisherFrontiers Media S.A.
dc.publisherFrontiers in Oncology
dc.relationFrontiers in Oncology, 2234-943X, Vol 11, 2021
dc.relationhttps://www.frontiersin.org/articles/10.3389/fonc.2021.787585/full
dc.rightshttp://creativecommons.org/licenses/by/4.0/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAcceso abierto
dc.rightsAtribución 4.0 Internacional
dc.titleResistance to KRAS g12c inhibitors in non-small cell lung cancer


Este ítem pertenece a la siguiente institución